Ostri Christoffer, la Cour Morten, Lund-Andersen Henrik
Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark.
Acta Ophthalmol. 2014 Aug;92(5):439-43. doi: 10.1111/aos.12249. Epub 2013 Aug 3.
Diabetic vitrectomy represents an end-point of diabetic retinopathy progression. This study was designed to estimate long-term incidence of diabetic vitrectomy and associated risk factors.
Retrospective review of prospectively collected data from a large diabetes centre between 1996 and 2010. Surgical history was obtained from The Danish National Patient Register.
The population consisted of 3980 patients with type 1 diabetes. Median follow-up was 10.0 years. In total, 106 patients underwent diabetic vitrectomy in the observation period. Surgery indications were nonclearing vitreous haemorrhage (43%) or tractional retinal detachment (57%). The cumulative incidence rates of diabetic vitrectomy were 1.6% after 5 years and 2.9% after 10 years. When excluding patients with no or mild diabetic retinopathy, the corresponding rates were higher; 3.7% and 6.4%, respectively (p < 0.001, log-rank test). The risk of reaching diabetic vitrectomy increased in patients experiencing glycosylated haemoglobin A1c > 75 mmol/mol in the observation period (p < 0.001, hazard ratio: 3.9, Cox regression analysis). Systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, diabetes duration, age, gender and nephropathy were not associated with an increased risk of reaching diabetic vitrectomy (p > 0.05 for all variables).
Diabetic vitrectomy is rarely required in a type 1 diabetes population with varying degrees of retinopathy, but the risk increases markedly with poor metabolic control.
糖尿病玻璃体切除术是糖尿病视网膜病变进展的一个终点。本研究旨在评估糖尿病玻璃体切除术的长期发病率及相关危险因素。
回顾性分析1996年至2010年期间从一个大型糖尿病中心前瞻性收集的数据。手术史来自丹麦国家患者登记处。
研究人群包括3980例1型糖尿病患者。中位随访时间为10.0年。在观察期内,共有106例患者接受了糖尿病玻璃体切除术。手术指征为玻璃体出血不吸收(43%)或牵拉性视网膜脱离(57%)。糖尿病玻璃体切除术的累积发病率在5年后为1.6%,10年后为2.9%。排除无糖尿病视网膜病变或轻度糖尿病视网膜病变的患者后,相应的发病率更高,分别为3.7%和6.4%(p<0.001,对数秩检验)。在观察期内糖化血红蛋白A1c>75 mmol/mol的患者中,接受糖尿病玻璃体切除术的风险增加(p<0.001,风险比:3.9,Cox回归分析)。收缩压≥140 mmHg、舒张压≥90 mmHg、糖尿病病程、年龄、性别和肾病与接受糖尿病玻璃体切除术的风险增加无关(所有变量p>0.05)。
在患有不同程度视网膜病变的1型糖尿病患者中,很少需要进行糖尿病玻璃体切除术,但随着代谢控制不佳,风险会显著增加。